Canadian children's inflammatory bowel disease study
Part of Digestive system clinical trials.
This study follows children with inflammatory bowel disease (IBD) to learn more about the disease and improve care. It may help doctors understand how to treat Crohn's disease, ulcerative colitis, or IBD that doesn't fit either diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child or teen diagnosed with inflammatory bowel disease (IBD).
- IBD includes Crohn's disease, ulcerative colitis, or IBD that is not clearly one type.
- You and your family must agree to participate and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects information from children who are newly diagnosed with inflammatory bowel disease (IBD) and follows them to understand safety in real life. It may help doctors improve early diagnosis and treatment planning for kids with IBD.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study looks at health records of children in Korea who have inflammatory bowel disease (Crohn's disease or ulcerative colitis) to understand their medical care, treatments, and healthcare use. Researchers are not testing a new drug—they're analyzing existing medical information to learn more about how these diseases are managed in children.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
This trial looks at early signs of inflammatory bowel disease (IBD) in adults who have had stomach or bowel symptoms for at least 3 weeks. It aims to understand how the disease progresses.
This study collects samples to learn how gut microbes, genetics, and body chemistry may relate to Crohn’s disease or ulcerative colitis. Your information and samples may help researchers understand disease patterns, but it does not test a new drug.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.